Page last updated: 2024-08-18

cyclohexanol and c-peptide

cyclohexanol has been researched along with c-peptide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnold, R; Fuder, H; Göke, B; Kleist, P; Littke, T; Lücker, PW; Stridde, E; Theiss, U; Wieckhorst, G1
Brvar, M; Koželj, G; Mašič, LP1

Trials

1 trial(s) available for cyclohexanol and c-peptide

ArticleYear
Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve.
    Digestion, 1995, Volume: 56, Issue:6

    Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Cyclohexanols; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Insulin; Male; Peptide Fragments; Protein Precursors

1995

Other Studies

1 other study(ies) available for cyclohexanol and c-peptide

ArticleYear
Hypoglycemia in venlafaxine overdose: a hypothesis of increased glucose uptake.
    European journal of clinical pharmacology, 2015, Volume: 71, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Blood Glucose; C-Peptide; Cyclohexanols; Drug Overdose; Female; Glucose; Humans; Hypoglycemia; Insulin; Venlafaxine Hydrochloride

2015